ANI Pharmaceuticals
ANIP
ANIP
204 hedge funds and large institutions have $1.07B invested in ANI Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 68 increasing their positions, 60 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
204
Holders Change
-3
Holders Change %
-1.45%
% of All Funds
2.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
68
Reduced
60
Closed
31
Calls
$188K
Puts
$597K
Net Calls
-$409K
Net Calls Change
-$337K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$55.4M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$32.9M |
| 3 |
3
Aberdeen Group
Edinburgh,
United Kingdom
|
$13.2M |
| 4 |
SCM
4
Sio Capital Management
New York
|
$8.85M |
| 5 |
DTC
5
Deep Track Capital
Greenwich,
Connecticut
|
$35.9M |
